Search research articles
Contact Us
Filters
Showing results (101-110 of 104) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 104 results.
Acta Physiologica (Oxford, England)
|
September 14, 2011
Reduction of breast cancer cell migration via up-regulation of TASK-3 two-pore domain K+ channel
G-W Lee, H S Park, E-J Kim, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
July 20, 2010
A pilot study of brain activation in children with trichotillomania during a visual-tactile symptom provocation task: a functional magnetic resonance imaging study
J A Lee, C K Kim, G H Jahng, et al.
Diabetes Research and Clinical Practice
|
April 1, 1992
Immunogenetic and nutritional profile in insulin-using youth-onset diabetics in Korea
K B Huh, H C Lee, H M Kim, et al.
Diabetes, Obesity & Metabolism
|
January 11, 2016
Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase-4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24-week multicentre, randomized, double-blind, placebo-controlled phase III trial
S Hong, C-Y Park, K A Han, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 104) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 104 results.
Acta Physiologica (Oxford, England)
|
September 14, 2011
Reduction of breast cancer cell migration via up-regulation of TASK-3 two-pore domain K+ channel
G-W Lee, H S Park, E-J Kim, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
July 20, 2010
A pilot study of brain activation in children with trichotillomania during a visual-tactile symptom provocation task: a functional magnetic resonance imaging study
J A Lee, C K Kim, G H Jahng, et al.
Diabetes Research and Clinical Practice
|
April 1, 1992
Immunogenetic and nutritional profile in insulin-using youth-onset diabetics in Korea
K B Huh, H C Lee, H M Kim, et al.
Diabetes, Obesity & Metabolism
|
January 11, 2016
Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase-4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24-week multicentre, randomized, double-blind, placebo-controlled phase III trial
S Hong, C-Y Park, K A Han, et al.
Page
of 11